CompletedPhase 2/3

Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax

United States50 participantsStarted 2005-07

Plain-language summary

The purpose of this study is to examine the efficacy of prophylactic antibiotics in patients with chest tubes for management of thoracic injuries in the reduction of the incidence of empyema as compared to placebo.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 16 years of age.
✓. Admission to Trauma, General Surgery, and/or Surgical Critical Care services.
✓. Traumatic pneumothorax, hemothorax or hemopneumothorax

Exclusion criteria

✕. Pregnancy
✕. Open fracture
✕. Immunocompromised
✕. Require antibiotics for treatment of other injuries
✕. Chest tube placement greater than 72hrs after admission

What they're measuring

efficacy of prophylactic antibiotics in reduction of empyema

Timeframe: 30 days

Trial details

NCT IDNCT01127880

SponsorSt. Luke's Hospital, Pennsylvania

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-12

View on ClinicalTrials.gov More Hemopneumothorax trials